Latest News and Press Releases

New York, United States, March 06, 2025 (GLOBE NEWSWIRE) -- The presence of microorganisms in the blood, such as bacteria, yeast, and other types of microorganisms, can be determined by performing a...

Dublin, Oct. 23, 2024 (GLOBE NEWSWIRE) -- The "Salivary Gland Infection Market Report Global Forecast by Type, Application, Country and Company Analysis 2024-2032" report has been added to ...

New York, United States, Feb. 29, 2024 (GLOBE NEWSWIRE) -- Onychomycosis is a fungal condition that affects the fingernails and toenails and can be painful, ugly, and persistent. Several types of...

Dublin, Dec. 19, 2023 (GLOBE NEWSWIRE) -- The "Global Blood Culture Test Market Size, Market Share, Application Analysis, Regional Outlook, Growth Trends, Key Players, Competitive Strategies and...

Dublin, Aug. 18, 2021 (GLOBE NEWSWIRE) -- The "Blood Culture Test Market: Global Industry Trends, Share, Size, Growth, Opportunity and Forecast 2021-2026" report has been added to...

Dublin, Dec. 02, 2020 (GLOBE NEWSWIRE) -- The "Blood Culture Test Market: Global Industry Trends, Share, Size, Growth, Opportunity and Forecast 2020-2025" report has been added to...

SOUTH SAN FRANCISCO, Calif. and TAIPEI, Taiwan, Aug. 26, 2020 (GLOBE NEWSWIRE) -- TLC (Nasdaq: TLC, TWO: 4152), a clinical-stage specialty pharmaceutical company developing novel nanomedicines to...

SAN DIEGO, Aug. 07, 2019 (GLOBE NEWSWIRE) -- Cidara Therapeutics, Inc. (Nasdaq: CDTX), a biotechnology company developing novel anti-infectives including immunotherapies, today announced that...

Data from second part of successful Phase 2 STRIVE trial further substantiate the efficacy, safety and tolerability of once-weekly rezafungin for first-line treatment of invasive Candida infections ...

SAN DIEGO, April 03, 2019 (GLOBE NEWSWIRE) -- Cidara Therapeutics, Inc. (Nasdaq: CDTX), a biotechnology company developing novel anti-infectives including immunotherapies, today announced that...